ABEV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ambev SA (ABEV) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows weak financial performance, neutral technical indicators, and no significant positive catalysts. While the analyst rating indicates some potential for future growth, the lack of immediate positive momentum and the absence of strong proprietary trading signals suggest holding off on investment for now.
The MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 45.302, and moving averages are converging without a clear trend. The stock is trading near its pivot level of 2.822, with resistance at 2.913 and support at 2.73. Overall, technical indicators do not suggest a strong buy signal.
Analyst Barclays raised the price target to $3 from $2.50, citing profitability-led earnings and cash flow growth potential in 2026.
Hedge funds are aggressively selling, with a 9796.69% increase in selling activity last quarter. Financial performance in Q4 2025 showed declines across revenue (-8.24%), net income (-10.94%), EPS (-9.68%), and gross margin (-1.96%). No recent news or congress trading data to support positive sentiment.
In Q4 2025, Ambev's revenue dropped by 8.24% YoY to 24.8 billion. Net income fell by 10.94% YoY to 4.35 billion, and EPS declined by 9.68% YoY to 0.28. Gross margin also decreased to 52.63%, down 1.96% YoY. These figures indicate a challenging financial quarter.
Barclays raised the price target to $3 from $2.50, maintaining an Equal Weight rating. Analysts see potential for profitability-led growth in 2026, but the current rating is neutral.
